AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
White House Wants Hospitals, Insurers to Provide Actual Costs of Care
Government officials say the objective is to encourage competition and reduce costs
Bipartisan Bill to Curb Drug Costs Backed by White House
Senate bill does not give Medicare bargaining power but would cap out-of-pocket payments by beneficiaries
AHA: Many With Atherosclerotic CVD Not Meeting LDL-C Goals
Of those patients receiving only a statin, 67.0 percent did not achieve recommended LDL-C goal
FDA Panel: Expand Use of Fish Oil Drug Vascepa
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients
1999 to 2016 Saw Increase in U.S. Adults Trying to Lose Weight
Parallel trends seen for increasing current measured body mass index and weight among adults
American Society of Nephrology, Nov. 7-10
The Annual Meeting of the American Society of Nephrology, Kidney Week 2019 The annual meeting of the American Society of Nephrology was held...
Survey of U.S. Registered Nurses Points to Worsening Shortages
Problem likely will be exacerbated with one in five nurses saying they will retire in the next five years
Minimum Age to Buy Tobacco, E-Cigarettes Raised in NY State
State police and Department of Health will conduct undercover investigations of retailers to enforce law
